Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7449299rdf:typepubmed:Citationlld:pubmed
pubmed-article:7449299lifeskim:mentionsumls-concept:C0005854lld:lifeskim
pubmed-article:7449299lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:7449299pubmed:dateCreated1981-3-27lld:pubmed
pubmed-article:7449299pubmed:abstractText1. Sixteen neurosurgical patients received (oral) beta-adrenoreceptor-blocking agents (beta-receptor blockers) for 3-22 days. 2. Lipophilic beta-receptor blockers (propranolol) and metoprolol appeared in cerebrospinal fluid at concentrations similar to the free drug plasma concentration. 3. Cerebrospinal fluid concentrations of beta-receptor blockers were poor predictors of brain concentrations. 4. Both lipophilic beta-receptor blockers appeared in high concentrations in the brain: the brain/plasma ratio was approximately 15:1. 5. Hydrophilic atenolol appeared at low concentrations in brain tissue (about 20 times lower than the lipophilic beta-receptor blockers): the brain/plasma ratio was approximately 0.1:1. 6. Central nervous system-related side effects associated mainly with lipophilic beta-receptor blockers possibly result from high brain tissue concentrations.lld:pubmed
pubmed-article:7449299pubmed:languageenglld:pubmed
pubmed-article:7449299pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7449299pubmed:citationSubsetIMlld:pubmed
pubmed-article:7449299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7449299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7449299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7449299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7449299pubmed:statusMEDLINElld:pubmed
pubmed-article:7449299pubmed:monthDeclld:pubmed
pubmed-article:7449299pubmed:issn0143-5221lld:pubmed
pubmed-article:7449299pubmed:authorpubmed-author:CameronM MMMlld:pubmed
pubmed-article:7449299pubmed:authorpubmed-author:McAinshJJlld:pubmed
pubmed-article:7449299pubmed:authorpubmed-author:CruickshankJ...lld:pubmed
pubmed-article:7449299pubmed:authorpubmed-author:Neil-DwyerGGlld:pubmed
pubmed-article:7449299pubmed:issnTypePrintlld:pubmed
pubmed-article:7449299pubmed:volume59 Suppl 6lld:pubmed
pubmed-article:7449299pubmed:ownerNLMlld:pubmed
pubmed-article:7449299pubmed:authorsCompleteYlld:pubmed
pubmed-article:7449299pubmed:pagination453s-455slld:pubmed
pubmed-article:7449299pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:meshHeadingpubmed-meshheading:7449299-...lld:pubmed
pubmed-article:7449299pubmed:year1980lld:pubmed
pubmed-article:7449299pubmed:articleTitlebeta-Adrenoreceptor-blocking agents and the blood-brain barrier.lld:pubmed
pubmed-article:7449299pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7449299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7449299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7449299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7449299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7449299lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7449299lld:pubmed